Prelude Capital Management’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,997
Closed -$2.06M – 1599
2026
Q2
$2.06M Sell
10,997
-6,076
-36% -$888K 0.15% 172
2026
Q1
$1.66M Buy
+17,073
New +$1.72M 0.13% 197
2025
Q4
– Sell
-20,000
Closed -$934K – 1523
2025
Q3
$934K Buy
+20,000
New +$783K 0.07% 319
2023
Q3
– Sell
-12,100
Closed -$324K – 1324
2023
Q2
$324K Buy
+12,100
New +$297K 0.02% 607

Other funds holding RVMD

Prelude Capital Management's RVMD Position: Q3 2026 in Review

Prelude Capital Management sold out of Revolution Medicines (RVMD) in Q3 2026, closing a stake of 10,997 shares — an estimated $2.06M sold.

Prelude Capital Management first reported a position in RVMD in Q2 2023 and held it in 4 quarters. The position peaked at $2.06M in Q2 2026. 760 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Prelude Capital Management reported no remaining Revolution Medicines position as of Q3 2026 after selling out during the quarter.
  • Prelude Capital Management sold 10,997 Revolution Medicines shares in Q3 2026, an estimated $2.06M.
  • Prelude Capital Management first reported a position in Revolution Medicines in Q2 2023 and held it in 4 quarters.
  • Prelude Capital Management's Revolution Medicines position peaked at $2.06M in Q2 2026.
  • 760 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Prelude Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.